Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Jiong Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5613-1195; OpenAlex author ID A5025071259. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers

Papers 7

  1. Characterization of DNA damage response deficiency in pancreatic cancer patients from China. Co-author DOI 10.1002/cac2.12238↗
  2. Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer. Co-author DOI 10.1016/j.ebiom.2022.103897↗
  3. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Co-author DOI 10.1038/s41421-021-00271-4↗
  4. A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-021-08375-6↗
  5. RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer. First author DOI 10.1007/s12032-020-01384-8↗
  6. Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients. Co-author DOI 10.18632/oncotarget.12447↗
  7. A prognostic index model to predict the clinical outcomes for advanced pancreatic cancer patients following palliative chemotherapy. Co-author DOI 10.1007/s00432-015-1953-y↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Feng Jiao · 5 shared papers, 2020–2022 · strength 0.55
  2. Jiujie Cui · 5 shared papers, 2020–2022 · strength 0.55
  3. Tiebo Mao · 4 shared papers, 2021–2022 · strength 0.43
  4. Haiyan Yang · 4 shared papers, 2015–2021 · strength 0.34
  5. Liwei Wang · 3 shared papers, 2020–2022 · strength 0.34
  6. Yu Wang · 3 shared papers, 2021–2022 · strength 0.32
  7. Xiaofei Zhang · 3 shared papers, 2021–2022 · strength 0.32
  8. Yongwei Sun · 3 shared papers, 2021–2022 · strength 0.32
  9. Jiayu Yao · 3 shared papers, 2021–2022 · strength 0.32
  10. Deliang Fu · 3 shared papers, 2021–2022 · strength 0.32
  11. Yingbin Liu · 2 shared papers, 2022 · strength 0.22
  12. Yuexiang Wang · 2 shared papers, 2022 · strength 0.22
  13. Liwei Wang · 2 shared papers, 2021 · strength 0.21
  14. Ming Quan · 1 shared paper, 2020 · strength 0.12
  15. Ting Han · 1 shared paper, 2021 · strength 0.11
  16. Liwei Wang · 2 shared papers, 2015–2016 · strength 0.11
  17. Yu Wang · 1 shared paper, 2022 · strength 0.11
  18. Qiang Liu · 1 shared paper, 2022 · strength 0.11
  19. Shumin Li · 1 shared paper, 2022 · strength 0.11
  20. Weiyu Ge · 1 shared paper, 2022 · strength 0.11
  21. Yiyi Liang · 1 shared paper, 2021 · strength 0.10
  22. Qing Xia · 1 shared paper, 2021 · strength 0.10
  23. Jing Xue · 1 shared paper, 2021 · strength 0.10
  24. Hai Xia Hu · 1 shared paper, 2016 · strength 0.06
  25. Lei Wang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.